SlideShare ist ein Scribd-Unternehmen logo
1 von 104
Measures of association
Measures of association learning objectives
1. Define and understand the difference between the concepts of “effects” and
“associations”
2. Use a contingency (2x2) table to organize information on disease occurrence
in time
3. Understand the differences between the additive and multiplicative scales
a. Identify the scale of each measure of association
4. Know how to calculate and interpret measures of association listed below
(this includes knowing the formulas)
a. Relative measures
i. Cumulative incidence ratio
ii. Incidence density ratio
iii. Prevalence ratio
iv. Odds ratio
b. Absolute measures
i. Attributable risk (aka risk difference)
ii. Attributable risk percent
iii. Population attributable risk
iv. Population attributable risk percent
c. Number needed to treat
5. Understand what the strength of an association captures
6. Understand what relative and absolute measures capture
7. Understand what attributable percentage measures capture
Measures of association outline
– Big picture
– Scales of measures
– The 2x2 table
– Measures of association
• Relative measures
• Absolute measures
• Other measures
– Summary
Big picture
• In epidemiology, we often compare measures of
disease frequency between different groups
– Building on measures of disease module
• Typically comparing disease frequency between
groups with different exposures
• The goal is to ascertain associations between
exposures and outcomes and, ultimately, effects
of exposures on outcomes
Big picture
• Reminder on the distinction between
associations and effects
• An association tells us about probabilities of past
events
– Carrying matches is associated with lung cancer
Big picture
• An effect is causal and it tells us how
probabilities change if conditions change
– If you remove matches from pockets in the
population, does the rate of lung cancer decrease?
?
Big picture
• Measures of association quantify the strength
and direction of associations between exposures
and outcomes
• Strength of association:
– Is exposure weakly related to outcome? Strongly?
Big picture
• Direction of association:
– Does exposure increase risk of disease (risk factor)?
– Does exposure decrease risk (protective factor)?
– Is there no association (null result)?
Big picture
• Recall counterfactual framework illustrated by an
“ideal experiment”
• A hypothetical study which, if we could actually
conduct it, would allow us to infer causality
– Population experiences one exposure and observed
for outcome over a given time period
– Roll back the clock
– Change the exposure but leave everything else the
same, observe for outcome over the same time period
– Compare the outcomes under both exposures: this is
the causal effect
Big picture
• In reality, the “ideal experiment” cannot be conducted
• We evaluate the associations between exposures and
outcomes by comparing outcomes between groups that
experienced different exposures
Big picture
• Measure of association does not necessarily (or
even typically) quantify a causal effect
• Associations may be explained by various
sources:
– Causal relation
– Chance (random error)
– Bias (systematic error)
Big picture
• Throughout course will enumerate the methods
for:
– Designing studies to minimize error (systematic and
random)
– Assessing the roles of systematic and random error
once a study is conducted (qualitatively and
quantitatively)
– Incorporating knowledge or assumptions about the
causal process
– Analytically removing or adjusting for error to the
extent possible
Big picture
• These are key steps to moving towards inferring
causality from associations
Measures of association outline
– Big picture
– Scales of measures
– The 2x2 table
– Measures of association
• Relative measures
• Absolute measures
• Other measures
– Causal perspective on scales and measures
– Summary
Scales of measures
• There are different scales for measuring
associations between variables
• Analogy: if you wanted to measure weight
changes you might measure:
– Weight loss/gain in lbs
– Weight loss/gain as a percentage of starting weight
– Change in BMI percentile
• Comparison of gain/loss between people would
depend on measure used
Scales of measures
• Similarly, there are different scales for
quantifying the size or strength of association
between an exposure and an outcome
Scales of measures
• Measures of association can be calculated on
two different scales:
– Relative scale (ratios)
– Absolute scale (differences)
• Each scale has several defining characteristics:
– Range of values that the measure of association can
take
– Null value: value at which there is no association
(value consistent with the null hypothesis of no
association)
Scales of measures
• The scale of a measure of association is critical
because measures on different scales capture
different things
• First focus on learning how the scales are
different
• We will discuss motivations for choosing relative
versus absolute measures towards the end of
this module
Scales of measures
Relative scale – ratio measures of association
• The ratio of two measures of diseases is on the
relative scale:
– Example: (rate among the exposed)/(rate among the
unexposed)
– IDexposed
/ IDunexposed
• Examples of relative measures include:
Cumulative incidence ratio (CIR), incidence
density ratio (IDR)
• The CIR and IDR are often referred to as risk
ratio or rate ratio respectively, and are
abbreviated RR
Scales of measures
Relative scale – ratio measures of association
• Range: zero to positive infinity
• Null value: 1
• CIR = 1 or IDR = 1 means the exposure is not
associated with the outcome
Scales of measures
Absolute scale – difference measures of
association
• The difference between two measures of
disease is on the absolute scale:
– Example: rate among the exposed – rate among the
unexposed
– IDexposed
– IDunexposed
• Examples of absolute measures include:
attributable risk/rate (AR), population attributable
risk/rate (PAR)
• Note that “attributable risk” often used
generically to include risks and rates
Scales of measures
Absolute scale – difference measures of
association
• Range: negative infinity to positive infinity
• Null value: 0
• AR = 0 means the exposure is not associated
with the outcome
Measures of association outline
– Big picture
– Scales of measures
– The 2x2 table
– Measures of association
• Relative measures
• Absolute measures
• Other measures
– Causal perspective on scales and measures
– Summary
2x2 table
• Count data is typically organized with a 2x2 or contingency table
• Example: with incidence data a/(a+b) = CIe
• What is CI in the total population?
2x2 table
• Incidence density data is also organized with a 2x2 or contingency
table
• Example: a/PTe
= IDe
2x2 table
• Note that Stata and the Kleinbaum text book present the
table “backwards” with exposure on top and disease on
the left
• Pay attention to the orientation of the table before
making calculations
2x2 table
Note on notation
– PTexposed
= PTe
– PTunexposed
= PTu
– PTtotal
= PTt
– Will also see applied to measures of disease including
CI, ID
Measures of association outline
– Big picture
– Scales of measures
– The 2x2 table
– Measures of association
• Relative measures
• Absolute measures
• Other measures
– Causal perspective on scales and measures
– Summary
Relative measures
• Measures to be discussed
– Risk/rate ratio
– Prevalence ratio
– Odds ratio
Relative measures
• Risk/rate ratio (RR) – aka relative risk
– “Risk” in relative risk used generically to include risk or rate
• Provides information about relative association between
an exposure and a disease
• The risk/rate of disease in the exposed is compared to
the same measure among the unexposed as a ratio
• RR = Rexposed
/ Runexposed
= Re
/ Ru
• Where R indicates either risk or rate – (i.e., CI
(cumulative incidence) or ID (incidence density))
Relative measures
• RR can be used to refer generically to these relative
measures
• CIR is the specific term when cumulative incidence is
used
• IDR is the specific term when incidence density is used
• Used to see term RR used generically for any relative
measure (including OR, PR) but current trend is toward
specific terms
Relative measures
• Interpretations of RR:
• Relative difference in the risk/rate of disease between
the exposed and unexposed
• Interpretation of RR=5: Risk/rate of disease in the
exposed is 5 times the risk/rate in the unexposed
• Interpretation of RR=0.5: Risk/rate of disease in the
exposed is 0.5 times the risk/rate in the unexposed
Relative measures
• Example: study of oral contraceptive (OC) use and
bacteriuria among women 16-49 yrs
over 1 year
• RR = ?
• What measures of disease incidence can we estimate
from this data?
• How do we compare them to estimate RR?
Relative measures
• Can estimate CIs
• Take ratio to estimate RR
• RR = CIR = CIe
/CIu
=
• RR = (27/482)/(77/1908) = 1.39
• Women who use OCs have 1.39 times the risk of
bacteriuria (over 1 year) compared with women who do
not use OCs
• Note that as with CI, CIR is only interpretable with
information on the time period over which it was
calculated
Relative measures
• Prevalence ratio (PR)
• Provides information about relative association between
an exposure and a disease, using prevalence as the
measure of disease
– Analogous to RR
• PR = Prevexposed
/ Prevunexposed
= Preve
/ Prevu
Relative measures
• Interpretations of PR:
• Relative difference in the prevalence of disease
between the exposed and unexposed
• Interpretation of PR=5: Prevalence of disease among
the exposed is 5 times the prevalence in the unexposed
• Interpretation of PR=0.5: Prevalence of disease in the
exposed is 0.5 times the prevalence of disease in the
unexposed
Relative measures
• A brief aside on odds
• Odds – two equivalent definitions
– Odds = number of people with event / number of people without
an event
– Odds = probability of event occurring / probability of event not
occurring = P / (1-P)
• Example:
– 10 people in a classroom of 50 have a cold
– Probability of having a cold = 10/50 = 0.2
– Probability of not having a cold = 40/50 = 0.8
– Odds of having a cold = 10/40 = 0.2/0.8 = 0.25
• Odds range from 0 to positive infinity
Relative measures
• Utility of odds will become apparent when we discuss
study design and analysis of epidemiologic data
– When a disease is rare, odds can be modeled in place of risks
with similar results
– In some study designs (case-control varieties) odds estimate
pseudo-risks/rates (more in study design)
Relative measures
• Odds ratio (OR)
• Provides information about relative association between
an exposure and a disease, using odds as the measure
of disease
– Analogous to RR
• OR = (Pe
/(1-Pe
))/(Pu
/(1-Pu
))
• OR = Odds(disease)e
/ Odds(disease)u
JC: discuss (Disease Odds) vs. (Exposure Odds)
Relative measures
• Interpretations of OR:
• Relative difference in the odds of disease between the
exposed and unexposed
• Interpretation of OR=5: Odds of disease is in the
exposed is 5 times the odds in the unexposed
• Interpretation of OR=0.5: The odds of disease in the
exposed is 0.5 times the odds of disease in the
unexposed
• Note: it is incorrect to interpret the odds ratio as the
risk/rate ratio
– Exception for particular case-control study designs (more in
study design module)
Relative measures
• OR always more extreme than RR (further from null)
– When the disease is rare the values will be close
– Note that this is not relevant for designs in which OR captures a
risk/rate ratio directly (more in study design)
Relative measures
• OR versus RR
• Example:
– Recall the example of students having a cold
• P=0.2
• Odds=0.25
– Say we wanted to compare this classroom to an office
– In the office, 10 out of 100 people have a cold.
• P = 10/100 = 0.1
• Odds = 10/90 = 0.111
– Exposed are students, unexposed are office workers, outcome
is cold
– RR comparing students to workers: RR = 0.2 / 0.1 = 2
– OR comparing students to workers: OR = 0.25 / 0.111 = 2.25
Relative measures
• OR = ?
• OR = Odds(dis)exposed
/Odds(dis)unexposed
• OR = (a/b)/(c/d) = ad/bc
• OR = (27x1831)/(77x455) = 1.41
• Women who use OCs have 1.41 times the odds of
bacteriuria compared to women who do not use OCs
JC: mention disease odds vs. exposure odds
Relative measures
• Formula review
– RR = Re
/ Ru
– PR = Preve
/ Prevu
– OR = (Pe
/(1-Pe
))/(Pu
/(1-Pu
))
– OR = Odds(dis)e
/Odds(dis)u
Relative measures
• Exercise for home (discuss in lab)
• Hypothetical RCT for injection drug users
– Primary outcomes are cessation of drug use
– HIV as a secondary outcome of interest
Relative measures
• Exercise at home / in lab
• 60 people randomized to a 12-month residential
detoxification program
– 49 tested HIV negative at the start of the trial
– At the end of the trial, 5 participants tested positive
for HIV who had been negative at the start of the trial
• 60 people randomized to 12-months of
outpatient treatment
– 50 tested HIV negative at the start of the trial
– At the end of the trial, 3 participants tested positive
for HIV who had been negative at the start of the trial
Relative measures
• Exercise at home / in lab
• Calculate and interpret relative measures of
association of potential interest from these trial
results
Measures of association outline
– Big picture
– Scales of measures
– The 2x2 table
– Measures of association
• Relative measures
• Absolute measures
• Other measures
– Summary
Absolute measures
• Measures to be discussed
– Attributable risk (AR) – aka risk/rate difference (RD)
– Attributable risk percent (AR%)
– Population attributable risk (PAR)
– Population attributable risk percent (PAR%)
Absolute measures
• Attributable risk (AR) – aka risk/rate difference (RD)
• “Risk” in attributable risk used generically to include risk
or rate
• Provides information about absolute association
between an exposure and a disease, or the excess risk
or rate of disease in the exposed
• AR = Rexposed
– Runexposed
• Where R indicates either risk or rate – (i.e., CI
(cumulative incidence) or ID (incidence density))
Absolute measures
• Interpretations of AR:
• Difference in risk/rate of disease between the exposed
and unexposed
• Excess risk/rate of disease in the exposed compared
with the unexposed
• AR has same units as the incidence measure used (risk
(dimensionless) if CI; rate (1/time) if ID)
Absolute measures
Szklo Figure 3-1
Absolute measures
• Example: study of oral contraceptive (OC) use and
bacteriuria among women 16-49 yrs
over 1 year
• AR = ?
• How do we compare cumulative incidence to estimate
AR?
Absolute measures
• Take difference to estimate AR
• AR = CIe
– CIu
=
• AR = (27/482)–(77/1908) = 0.01566
• Women who use OCs have 0.01566 higher risk of
bacteriuria compared with women who do not use OCs
over 1 year
• Can multiply by a population size to facilitate
interpretation: 0.01566x100,000 = 1566/100,000
• Among every 100,000 women who use OCs there are
1566 excess cases of bacteriuria compared with women
who do not use OCs over 1 year
Absolute measures
• Attributable risk percent (AR%)
• Provides information about the excess incidence in the
exposed (AR) as a percentage of incidence in the
exposed population
• AR% = (Rexposed
– Runexposed
) / Rexposed
x 100
• AR% = AR/ Rexposed
x 100
Absolute measures
• Interpretations of AR%:
• Percentage of all disease incidence among the exposed
that is associated with the exposure
• Percentage of disease incidence in the exposed that is
in excess of the incidence in the unexposed
Absolute measures
Szklo Figure 3-1
100% of incidence
in the exposed
population AR% - percentage of
disease incidence in
the exposed that is in
excess of the
incidence in the
unexposed
Absolute measures
• AR% = ?
• AR% = (CIe
– CIu
)/CIe
x 100
• AR% = (27/482)–(77/1908)/(27/482) x 100 = 28%
• Of the bacteriuria incidence among women who use
OCs, 28% is in excess of the incidence in women who
do not use OCs
Absolute measures
• Attributable risk percent (AR%) is analogous to efficacy
for an intervention (e.g., vaccine, other treatment)
• The control group is considered “exposed”
• The treatment group is considered “unexposed”
• AR% = (Rexposed
– Runexposed
) / Rexposed
x 100
• Efficacy% = (Rcontrol
– Rtreatment
) / Rcontrol
x 100
• Percentage of disease incidence in the control group
that is in excess of the incidence in the treatment group
Absolute measures
• Population attributable risk (PAR)
• Provides information about the excess risk or rate of
disease in the entire population (not just among the
exposed as with AR)
– Sometimes the AR is called the “attributable risk among the
exposed” to make this distinction clear
• PAR = Rtotal
– Runexposed
• Alternative formulation:
• PAR = (AR)(Pe
)
– Pe
= prevalence of the exposure in the total population
– See extra slides for derivation
• Alternative formulation useful if estimating PAR for a
total population other than your study population for
which you have an estimate of Pe
Absolute measures
• Interpretations of PAR:
• Excess risk/rate of disease in the total population
compared with the unexposed
• If association is believed to be causal, PAR can be used
to estimate the impact of an exposure on the health of a
population of interest
• PAR will never be larger than AR in a given population
• PAR has same units as the incidence measure used
(risk (dimensionless) if CI; rate (1/time) if ID)
Absolute measures
• PAR = ?
• PAR = CIt
– CIu
=
• PAR = (104/2390)–(77/1908) = 0.00316
• In the total population of women there is 0.00316 higher
risk of bacteriuria compared with women who do not
use OCs
• Can multiply by a population size to facilitate
interpretation: 0.00316x100,000 = 316/100,000
• There are 316 excess cases of bacteriuria for every
100,000 women in the total population compared with
women who do not use OCs
JC: review NNT
Absolute measures
• Comparison of AR and PAR
• AR = 1566/100,000
• PAR = 316/100,000
• PAR < AR
• Why is this the case?
Absolute measures
• Population attributable risk percent (PAR%)
• Provides information about the excess incidence in the
total population (PAR) as a percentage of incidence in
the total population
• PAR% = (Rtotal
– Runexposed
) / Rtotal
x 100
• PAR% = (PAR / Rtotal
) x 100
Absolute measures
• PAR% = ?
• PAR% = (CIt
– CIu
)/CIt
x 100
• PAR% = (104/2390)–(77/1908)/(104/2390) x 100 =
7.3%
• Of the bacteriuria incidence in the total population of
women, 7% is in excess of the incidence in women who
do not use OCs
Absolute measures
• Comparison of AR% and PAR%
• AR% = 28%
• PAR% = 7%
• PAR% < AR%
• Why is this the case?
Absolute measures
Szklo Figure 3-2
Exposure uncommon
in total population
Exposure common in
total population
Absolute measures
• AR versus PAR
– The AR depends only on the strength of the relation
between the exposure and the disease
– The PAR depends both on the strength of the relation
and the prevalence of the exposure
Absolute measures
• AR = Rexposed
– Runexposed
• PAR = Rtotal
– Runexposed
• Think of Rtotal
(risk/rate in total population) as a weighted
average of the risk/rate among the exposed and
unexposed
• Weighted by the prevalence of the exposure (Pe
):
– Rt
= (Pe
)Re
+ (Pu
)Ru
– Rt
= (Pe
)Re
+ (1-Pe
)Ru
– When Pe
is close to 1 (and 1- Pe
is close to 0), Rt
is close to Re
and thus PAR is close to AR
– When Pe
is close to 0 (and 1- Pe
is close to 1), Rt
is close to Ru
(not Re
) and thus PAR is much smaller than AR
Absolute measures
Szklo Figure 3-2
Prevalence of exposure not depicted here, but reflected in different magnitudes
of PAR
Pe
is close to 0, Rt
is
close to Ru
(not Re
) and
thus PAR is much smaller
than AR
Pe
is close to 1, Rt
is
close to Re
and thus PAR
is close to AR
– An exposure with a large AR can have a low PAR if
the exposure is uncommon
– Example: extremely carcinogenic but rare chemical
• Removing an exposure with a large AR but a small PAR
would not improve the overall health of the population
appreciably
Absolute measures
Absolute measures
• There are some study designs (case-control) for which
measures of disease cannot be estimated – only the
odds ratio (OR), a relative measure, can be calculated
(more in study design)
• For these studies, there are alternative formulas for the
absolute measures that can be applied – they require
making some assumptions and/or bringing in outside
information
Absolute measures
• Alternative formulation for AR%
• Additional information/assumptions
– OR estimates risk/rate ratio
• AR% = [(OR – 1) / OR] x 100
• Alternative formula is a simple algebraic transformation
of original formula
– Dividing (Re
– Ru
) / Re
by Ru
– ((Re
/Ru
)-(Ru
/Ru
)) / (Re
/Ru
)
– (RR-1)/RR
– RR estimated by OR*
– *How well OR estimates risk or rate ratio depends on design of
case-control study and on how common disease is for
cumulative case-control
Absolute measures
• Alternative formulation for PAR%
• Additional information/assumptions
– OR estimates risk/rate ratio
– Prevalence of exposure in the total population can be estimated
as the proportion of non-diseased individuals exposed, or from
another source: Pe
– PAR% = [((Pe
)(OR-1)) / ((Pe
)(OR-1) + 1)] x 100
• Note Miettinen 1974 other formulation
– PAR% = AR% x (proportion exposed among diseased)
– Will provide a different estimate than formulation above
Absolute measures
• Derivation of alternative formula for PAR%
• Think of Rtotal
(risk/rate in total population) as a weighted
average of the risk/rate among the exposed and
unexposed
• Weighted by the prevalence of the exposure:
– Rt
= (Re
)(Pe
) + (Ru
)(1-Pe
)
• Substitute into original equation
– PAR% = (Rt
– Ru
)/ Rt
– PAR% = ((Re
)(Pe
) + (Ru
)(1-Pe
) – Ru
)/ (Re
)(Pe
) + (Ru
)(1-Pe
)
– PAR% = ((Re
)(Pe
) + (Ru
)-(Ru
Pe
) – Ru
)/ (Re
)(Pe
) + (Ru
)-(Ru
Pe
)
Absolute measures
• Divide numerator and denominator by Ru
– PAR% = ((Re
)(Pe
)/Ru
+ 1 - Pe
–1)/ (Re
)(Pe
)/Ru
+ 1-Pe
– PAR% = ((Re
)(Pe
)/Ru
- Pe
)/ (Re
)(Pe
)/Ru
- Pe
+ 1
– PAR% = (Pe
(Re
/Ru
- 1)/ Pe
(Re
/Ru
– 1) + 1
• Note that RR = Re
/ Ru
therefore if OR estimates RR
– PAR% = [(Pe
)(OR-1)] / [(Pe
)(OR-1) + 1]
Absolute measures
• Alternative formulation for AR, PAR
• Additional information/assumptions
– OR estimates risk/rate ratio
– Prevalence of exposure in the total population can be estimated
as the proportion of non-diseased individuals exposed, or from
an outside source: Pe
– Risk/rate for the total population can be estimated, usually from
an outside source: Rt
• Ru
= (Rt
) / ((OR)(Pe
) + (1- Pe
))
• Re
= (OR)(Ru
)
• AR = Re
-Ru
• PAR = Rt
-Ru
Absolute measures
• Derivation of alternative formulas for AR and PAR
• Think of Rtotal
(risk/rate in total population) as a weighted
average of the risk/rate among the exposed and
unexposed
• Weighted by the prevalence of the exposure:
– Rt
= (Re
)(Pe
) + (Ru
)(1- Pe
)
• Note that RR = Re
/ Ru
therefore if OR estimates RR
– Re
= (OR)(Ru
)
– Rt
= (OR)(Ru
)(Pe
) + (Ru
)(1- Pe
)
• Solve for Ru
– Ru
= (Rt
) / ((OR)(Pe
) + (1- Pe
))
– Re
= (OR)(Ru
)
Absolute measures
• Formula review
– AR = Rexposed
– Runexposed
– AR% = [(Rexposed
– Runexposed
) / Rexposed
] x 100
– PAR = Rtotal
– Runexposed
– PAR = (AR)(Pe
)
– PAR% = [(Rtotal
– Runexposed
) / Rtotal
] x 100
– AR% = [(OR – 1) / OR] x 100
– PAR% = [((Pe
)(OR-1)) / ((Pe
)(OR-1) + 1)] x 100
– AR = (OR)(Ru
) - (Rt
/ [(OR)(Pe
) + (1- Pe
)])
– PAR = Rt
- [(Rt
)/ ((OR)(Pe
) + (1- Pe
))]
Properties of scales
• Absolute measures are symmetrical around 0
– Exposure associated with higher risk/rate is indicated
by a positive value (e.g., AR = 0.01)
– Exposure associated with lower risk/rate is indicated
by a negative value (e.g., AR = -0.01)
– Magnitudes of negative and positive ARs with same
numeric value are equivalent but in opposite
directions (e.g., AR = 0.01 same magnitude as AR =
-0.01)
Properties of scales
• Relative measures are asymmetrical around 1
– Exposure associated with higher risk/rate is indicated
by a value >1 (e.g., RR = 2)
– Exposure associated with lower risk/rate is indicated
by a value 0-1 (e.g., RR = 0.5)
– To calculate a relative measure’s equivalent on the
other side of the null you have to take its inverse
(1/RR)
• RR = 2 is of equivalent strength to a protective factor with
RR = 1/2 = 0. 5
Properties of scales
• Relative measures – on arithmetic and log
scales
Properties of scales
• Due to the asymmetry of relative measures
– Log-transformed (natural log) axes are often used to
graphically present relative measures
– Variances of relative measures are calculated on the
log scale, and any calculations based on the variance
(e.g., confidence intervals) are completed on the log
scale before returning to the relative measure scale
Variance estimates
• Approximate variance estimates for measures of
association (some are in Szklo appendix A)
• Variance of:
– ln(IDR) = (1/a) + (1/b)
– ln(CIR) = (b / a(a+b)) + (d / c(c+d))
– ln(OR) = (1/a) + (1/b) + (1/c) + (1/d)
• Small cells inflate variance
Other measures
• Number needed to treat (NNT)
– Related to attributable risk
• Provides information about the number of
people you would have to remove exposure
from to prevent one case of disease
• NNT = 1 / AR
– The number (of exposed persons) needed to treat is
the reciprocal of the attributable risk
• Not appropriate unless you believe the relation
is causal
Other measures
• Example of OCs and bacteriuria
• AR = 0.01566
• NNT = 1/AR = 1/0.01566 = 64
• 64 OC users need to stop using OCs to eliminate one
case of bacteriuria
Absolute measures
• Exercise
• Recall our hypothetical RCT
• 60 people randomized to a 12-month residential
detoxification program
– 49 tested HIV negative at the start of the trial
– At the end of the trial, 5 participants tested positive
for HIV who had been negative at the start of the trial
• 60 people randomized to 12-months of
outpatient treatment
– 50 tested HIV negative at the start of the trial
– At the end of the trial, 3 participants tested positive
for HIV who had been negative at the start of the trial
Measures of association outline
– Big picture
– Scales of measures
– The 2x2 table
– Measures of association
• Relative measures
• Absolute measures
• Other measures
– Summary
Measures of association outline
– Big picture
– Scales of measures
– The 2x2 table
– Measures of association
• Relative measures
• Absolute measures
• Other measures
– Summary
Summary
• Measures of disease among groups with different
exposures are compared in observational epidemiology
• These comparisons are made with measures of
association between exposures and diseases
• Introduced to a variety of measures of association
broadly classified as relative or additive
Re
/Ru
Re
-Ru
Summary
• While the relative have been more commonly used, the
additive have been argued to be better for purposes of
identifying etiology and estimating public health impact
• Insights from two of the theoretical causal models
elucidate why this argument has been made, and
elucidate what relative and absolute measures estimate
Summary
Variety of terms used for measures of association
discussed today
• “Risk” often used generically to include rates (ID), risks
(CI) and even prevalence
Summary
Relative measures
• Cumulative incidence ratio (CIR)
• Incidence density ratio (IDR)
• Prevalence ratio (PR)
• Rate/risk ratio = Relative risk (RR)
• Odds ratio (OR)
Summary
Absolute measures
• Attributable risk (AR) = Risk/rate difference = Excess risk
• Population attributable risk (PAR) = Population risk/rate
difference
• Attributable risk percent (AR%) = Etiologic fraction =
Attributable proportion among the exposed
• Population attributable risk percent (PAR%) =
Attributable proportion in the total population
Summary
• Have only examined what are called “crude” measures
of association
– Compared exposed and unexposed populations without
considering other variables that may differ between the
populations
– Later in the course we will discuss how to deal analytically with
other variables that may be different between the exposed and
unexposed and that thus make the populations not
exchangeable (to be discussed in confounding)
Extra slides
Absolute measures
• Alternative formulation:
• PAR = (AR)(Pe
)
• Where does this come from?
• PAR = Rt
– Ru
• PAR = [(Pe
)Re
+ (1-Pe
)Ru
] - Ru
• PAR = (Pe
)Re
+ Ru
- (Pe
)Ru
- Ru
• PAR = (Pe
)Re
- (Pe
)Ru
• PAR = (Re
- Ru
)(Pe
)
• PAR = (AR)(Pe
)
Causal perspective
• When we estimate AR, PAR, AR% or PAR% (whether
with counterfactual populations or in observational data)
they will only provide a lower bound of the true
incidence or fraction of incidence due to the exposure
mechanistically (think of the pies) – unless exposure
acts independent of background causes
Causal perspective
Szklo Figure 3-1
Incidence caused
by mechanism
including
exposure
In absence of
exposure, another
causal mechanism
(background cause)
was completed
within study time
frame
Causal perspective
Population unexposed for a given time period, population exposed over same
period
Rates/risks compared are causal
p1+p3 p1+p2
Counterfactual Counterfactual
Causal perspective
• Extreme example – mechanism including your exposure
causes disease 1 day earlier than would have occurred
otherwise from background causes
• In the exposed, your exposure mechanistically caused
100% of disease
• In your data the rate of disease appears the same in the
exposed and unexposed and you infer 0% of disease
caused by your exposure (ME3 p63, 297 for elaborated
discussion)
• Type 2 (slide 74) individuals (in this example 100% of
them) had disease caused by exposure when exposed,
but caused by another mechanism when not exposed
• Thus incidence due to specific causal mechanisms
cannot be estimated from epidemiologic data
Relative measures
• OR – exposure OR vs disease OR
– Exposure OR = odds(E|D)/odds(E|Dnot)
– EOR = (a/c)/(b/d) = ad/bc
– Disease OR = odd(D|E)/odds(D|Enot)
– DOR = (a/b)/(c/d) = ad/bc
– Exposure OR = disease OR

Weitere ähnliche Inhalte

Was ist angesagt?

Measurement of epidemiology.pptx
Measurement of epidemiology.pptxMeasurement of epidemiology.pptx
Measurement of epidemiology.pptxradha maharjan
 
Measures of association 2013
Measures of association 2013Measures of association 2013
Measures of association 2013dinahoefer11
 
Basic concepts and principles of epidemiology
Basic concepts and  principles of epidemiologyBasic concepts and  principles of epidemiology
Basic concepts and principles of epidemiologyDr. Dharmendra Gahwai
 
Cross sectional study by Dr Abhishek Kumar
Cross sectional study by Dr Abhishek KumarCross sectional study by Dr Abhishek Kumar
Cross sectional study by Dr Abhishek Kumarak07mail
 
Categorical data analysis
Categorical data analysisCategorical data analysis
Categorical data analysisSumit Das
 
Relative and Atribute Risk
Relative and Atribute RiskRelative and Atribute Risk
Relative and Atribute RiskTauseef Jawaid
 
Nested case control,
Nested case control,Nested case control,
Nested case control,shefali jain
 
Survival analysis
Survival analysisSurvival analysis
Survival analysisHar Jindal
 
Common measures of association in medical research (UPDATED) 2013
Common measures of association in medical research (UPDATED) 2013Common measures of association in medical research (UPDATED) 2013
Common measures of association in medical research (UPDATED) 2013Pat Barlow
 
An Introduction to Infectious Disease Modeling
An Introduction to Infectious Disease ModelingAn Introduction to Infectious Disease Modeling
An Introduction to Infectious Disease ModelingInsideScientific
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designsIsmail Qamar
 
Epidemiological statistics
Epidemiological statisticsEpidemiological statistics
Epidemiological statisticsGarima Aggarwal
 

Was ist angesagt? (20)

Introduction to Biostatistics
Introduction to BiostatisticsIntroduction to Biostatistics
Introduction to Biostatistics
 
Standerdization
StanderdizationStanderdization
Standerdization
 
Epidemiology Study Design
Epidemiology Study DesignEpidemiology Study Design
Epidemiology Study Design
 
Measurement of epidemiology.pptx
Measurement of epidemiology.pptxMeasurement of epidemiology.pptx
Measurement of epidemiology.pptx
 
Measures of association 2013
Measures of association 2013Measures of association 2013
Measures of association 2013
 
Basic concepts and principles of epidemiology
Basic concepts and  principles of epidemiologyBasic concepts and  principles of epidemiology
Basic concepts and principles of epidemiology
 
Cross sectional study by Dr Abhishek Kumar
Cross sectional study by Dr Abhishek KumarCross sectional study by Dr Abhishek Kumar
Cross sectional study by Dr Abhishek Kumar
 
Categorical data analysis
Categorical data analysisCategorical data analysis
Categorical data analysis
 
Relative and Atribute Risk
Relative and Atribute RiskRelative and Atribute Risk
Relative and Atribute Risk
 
Measuring Disease Frequency
Measuring Disease FrequencyMeasuring Disease Frequency
Measuring Disease Frequency
 
Cross sec study dr rahul
Cross sec study dr rahulCross sec study dr rahul
Cross sec study dr rahul
 
Survival analysis
Survival  analysisSurvival  analysis
Survival analysis
 
Risk Comparison
Risk ComparisonRisk Comparison
Risk Comparison
 
Nested case control,
Nested case control,Nested case control,
Nested case control,
 
Survival analysis
Survival analysisSurvival analysis
Survival analysis
 
Common measures of association in medical research (UPDATED) 2013
Common measures of association in medical research (UPDATED) 2013Common measures of association in medical research (UPDATED) 2013
Common measures of association in medical research (UPDATED) 2013
 
An Introduction to Infectious Disease Modeling
An Introduction to Infectious Disease ModelingAn Introduction to Infectious Disease Modeling
An Introduction to Infectious Disease Modeling
 
3.dr swe swe latt introduction to epidemiology
3.dr swe swe latt introduction to epidemiology3.dr swe swe latt introduction to epidemiology
3.dr swe swe latt introduction to epidemiology
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
 
Epidemiological statistics
Epidemiological statisticsEpidemiological statistics
Epidemiological statistics
 

Andere mochten auch

What does an odds ratio or relative risk mean?
What does an odds ratio or relative risk mean? What does an odds ratio or relative risk mean?
What does an odds ratio or relative risk mean? Terry Shaneyfelt
 
Odds ratio y riesgo relativo
Odds ratio y riesgo relativoOdds ratio y riesgo relativo
Odds ratio y riesgo relativodj_jdo
 
Measurements in epidemiology
Measurements in epidemiologyMeasurements in epidemiology
Measurements in epidemiologyRizwan S A
 
association and causation
association and causationassociation and causation
association and causationguestc43c63
 
2014 lab slides_mo_a
2014 lab slides_mo_a2014 lab slides_mo_a
2014 lab slides_mo_aA M
 
Advancing English Language Teaching through TESOL Standards
Advancing English Language Teaching through TESOL StandardsAdvancing English Language Teaching through TESOL Standards
Advancing English Language Teaching through TESOL StandardsJohn Segota
 
Research Designs
Research DesignsResearch Designs
Research DesignsAravind L R
 
Math3010 week 6
Math3010 week 6Math3010 week 6
Math3010 week 6stanbridge
 
3 Major Trends in ELT Technology
3 Major Trends in ELT Technology3 Major Trends in ELT Technology
3 Major Trends in ELT Technologysumaira zaheer
 
Sexually Transmitted Infections
Sexually Transmitted InfectionsSexually Transmitted Infections
Sexually Transmitted Infectionsjenniferdole
 
Common measures of association in medical research handout
Common measures of association in medical research handoutCommon measures of association in medical research handout
Common measures of association in medical research handoutPat Barlow
 
Sexually transmitted infections
Sexually transmitted infectionsSexually transmitted infections
Sexually transmitted infectionsMalathi Murugesan
 
Dr Vivek Baliga - The Basics Of Medical Statistics
Dr Vivek Baliga - The Basics Of Medical StatisticsDr Vivek Baliga - The Basics Of Medical Statistics
Dr Vivek Baliga - The Basics Of Medical StatisticsDr Vivek Baliga
 
Scatter plots
Scatter plotsScatter plots
Scatter plotsMs. Jones
 
Medical research and study design
Medical research and study designMedical research and study design
Medical research and study designNaveen Phuyal
 

Andere mochten auch (20)

Odds ratio
Odds ratioOdds ratio
Odds ratio
 
Odds ratio
Odds ratioOdds ratio
Odds ratio
 
What does an odds ratio or relative risk mean?
What does an odds ratio or relative risk mean? What does an odds ratio or relative risk mean?
What does an odds ratio or relative risk mean?
 
Odds ratios y Riesgos relativos
Odds ratios y Riesgos relativosOdds ratios y Riesgos relativos
Odds ratios y Riesgos relativos
 
Odds ratio y riesgo relativo
Odds ratio y riesgo relativoOdds ratio y riesgo relativo
Odds ratio y riesgo relativo
 
Measurements in epidemiology
Measurements in epidemiologyMeasurements in epidemiology
Measurements in epidemiology
 
association and causation
association and causationassociation and causation
association and causation
 
2014 lab slides_mo_a
2014 lab slides_mo_a2014 lab slides_mo_a
2014 lab slides_mo_a
 
Dit ppt
Dit pptDit ppt
Dit ppt
 
Advancing English Language Teaching through TESOL Standards
Advancing English Language Teaching through TESOL StandardsAdvancing English Language Teaching through TESOL Standards
Advancing English Language Teaching through TESOL Standards
 
Research Designs
Research DesignsResearch Designs
Research Designs
 
Math3010 week 6
Math3010 week 6Math3010 week 6
Math3010 week 6
 
3 Major Trends in ELT Technology
3 Major Trends in ELT Technology3 Major Trends in ELT Technology
3 Major Trends in ELT Technology
 
Presentation
PresentationPresentation
Presentation
 
Sexually Transmitted Infections
Sexually Transmitted InfectionsSexually Transmitted Infections
Sexually Transmitted Infections
 
Common measures of association in medical research handout
Common measures of association in medical research handoutCommon measures of association in medical research handout
Common measures of association in medical research handout
 
Sexually transmitted infections
Sexually transmitted infectionsSexually transmitted infections
Sexually transmitted infections
 
Dr Vivek Baliga - The Basics Of Medical Statistics
Dr Vivek Baliga - The Basics Of Medical StatisticsDr Vivek Baliga - The Basics Of Medical Statistics
Dr Vivek Baliga - The Basics Of Medical Statistics
 
Scatter plots
Scatter plotsScatter plots
Scatter plots
 
Medical research and study design
Medical research and study designMedical research and study design
Medical research and study design
 

Ähnlich wie 2. ph250b.14 measures of association 1

2.2 scales of measures
2.2 scales of measures2.2 scales of measures
2.2 scales of measuresA M
 
2.1 big picture
2.1 big picture2.1 big picture
2.1 big pictureA M
 
2.4.1 relative measures
2.4.1 relative measures2.4.1 relative measures
2.4.1 relative measuresA M
 
Medpage guide-to-biostatistics
Medpage guide-to-biostatisticsMedpage guide-to-biostatistics
Medpage guide-to-biostatisticsElsa von Licy
 
Bio-Statistics in Bio-Medical research
Bio-Statistics in Bio-Medical researchBio-Statistics in Bio-Medical research
Bio-Statistics in Bio-Medical researchShinjan Patra
 
Introduction to statistics in health care
Introduction to statistics in health care Introduction to statistics in health care
Introduction to statistics in health care Dhasarathi Kumar
 
Relative and Attributable Risk For Graduate and Postgraduate Students
Relative and Attributable Risk For Graduate and Postgraduate StudentsRelative and Attributable Risk For Graduate and Postgraduate Students
Relative and Attributable Risk For Graduate and Postgraduate StudentsTauseef Jawaid
 
Epidemological methods
Epidemological methodsEpidemological methods
Epidemological methodsKundan Singh
 
Case-control study un.uob.pptx
Case-control study un.uob.pptxCase-control study un.uob.pptx
Case-control study un.uob.pptxKifluKumera
 
Imran rizvi statistics in meta analysis
Imran rizvi statistics in meta analysisImran rizvi statistics in meta analysis
Imran rizvi statistics in meta analysisImran Rizvi
 
statistics introduction.ppt
statistics introduction.pptstatistics introduction.ppt
statistics introduction.pptCHANDAN PADHAN
 
ANALYTICAL STUDIES.pptx
ANALYTICAL STUDIES.pptxANALYTICAL STUDIES.pptx
ANALYTICAL STUDIES.pptxpayalrathod14
 
2.5 summary
2.5 summary2.5 summary
2.5 summaryA M
 
83341ch12jacobsen-150812175733-lva1-app6891.pdf
83341ch12jacobsen-150812175733-lva1-app6891.pdf83341ch12jacobsen-150812175733-lva1-app6891.pdf
83341ch12jacobsen-150812175733-lva1-app6891.pdfunoi1
 

Ähnlich wie 2. ph250b.14 measures of association 1 (20)

2.2 scales of measures
2.2 scales of measures2.2 scales of measures
2.2 scales of measures
 
2.1 big picture
2.1 big picture2.1 big picture
2.1 big picture
 
2.4.1 relative measures
2.4.1 relative measures2.4.1 relative measures
2.4.1 relative measures
 
Understanding statistics in research
Understanding statistics in researchUnderstanding statistics in research
Understanding statistics in research
 
Medpage guide-to-biostatistics
Medpage guide-to-biostatisticsMedpage guide-to-biostatistics
Medpage guide-to-biostatistics
 
Bio-Statistics in Bio-Medical research
Bio-Statistics in Bio-Medical researchBio-Statistics in Bio-Medical research
Bio-Statistics in Bio-Medical research
 
Biostatistics
BiostatisticsBiostatistics
Biostatistics
 
83341 ch08 jacobsen
83341 ch08 jacobsen83341 ch08 jacobsen
83341 ch08 jacobsen
 
Types of study design
Types of study designTypes of study design
Types of study design
 
Introduction to statistics in health care
Introduction to statistics in health care Introduction to statistics in health care
Introduction to statistics in health care
 
Relative and Attributable Risk For Graduate and Postgraduate Students
Relative and Attributable Risk For Graduate and Postgraduate StudentsRelative and Attributable Risk For Graduate and Postgraduate Students
Relative and Attributable Risk For Graduate and Postgraduate Students
 
Epidemological methods
Epidemological methodsEpidemological methods
Epidemological methods
 
Statistics.pptx
Statistics.pptxStatistics.pptx
Statistics.pptx
 
Case-control study un.uob.pptx
Case-control study un.uob.pptxCase-control study un.uob.pptx
Case-control study un.uob.pptx
 
Imran rizvi statistics in meta analysis
Imran rizvi statistics in meta analysisImran rizvi statistics in meta analysis
Imran rizvi statistics in meta analysis
 
statistics introduction.ppt
statistics introduction.pptstatistics introduction.ppt
statistics introduction.ppt
 
ANALYTICAL STUDIES.pptx
ANALYTICAL STUDIES.pptxANALYTICAL STUDIES.pptx
ANALYTICAL STUDIES.pptx
 
COHORT STUDY.pptx
COHORT STUDY.pptxCOHORT STUDY.pptx
COHORT STUDY.pptx
 
2.5 summary
2.5 summary2.5 summary
2.5 summary
 
83341ch12jacobsen-150812175733-lva1-app6891.pdf
83341ch12jacobsen-150812175733-lva1-app6891.pdf83341ch12jacobsen-150812175733-lva1-app6891.pdf
83341ch12jacobsen-150812175733-lva1-app6891.pdf
 

Mehr von A M

Transparency7
Transparency7Transparency7
Transparency7A M
 
Transparency6
Transparency6Transparency6
Transparency6A M
 
Transparency5
Transparency5Transparency5
Transparency5A M
 
Transparency4
Transparency4Transparency4
Transparency4A M
 
Transparency3
Transparency3Transparency3
Transparency3A M
 
Transparency2
Transparency2Transparency2
Transparency2A M
 
Transparency1
Transparency1Transparency1
Transparency1A M
 
5.3.5 causal inference in research
5.3.5 causal inference in research5.3.5 causal inference in research
5.3.5 causal inference in researchA M
 
5.3.4 reporting em
5.3.4 reporting em5.3.4 reporting em
5.3.4 reporting emA M
 
5.3.3 potential outcomes em
5.3.3 potential outcomes em5.3.3 potential outcomes em
5.3.3 potential outcomes emA M
 
5.3.2 sufficient cause em
5.3.2 sufficient cause em5.3.2 sufficient cause em
5.3.2 sufficient cause emA M
 
5.3.1 causal em
5.3.1 causal em5.3.1 causal em
5.3.1 causal emA M
 
5.2.3 dags for selection bias
5.2.3 dags for selection bias5.2.3 dags for selection bias
5.2.3 dags for selection biasA M
 
5.2.2 dags for confounding
5.2.2 dags for confounding5.2.2 dags for confounding
5.2.2 dags for confoundingA M
 
5.1.3 hills criteria
5.1.3 hills criteria5.1.3 hills criteria
5.1.3 hills criteriaA M
 
5.1.2 counterfactual framework
5.1.2 counterfactual framework5.1.2 counterfactual framework
5.1.2 counterfactual frameworkA M
 
5.1.1 sufficient component cause model
5.1.1 sufficient component cause model5.1.1 sufficient component cause model
5.1.1 sufficient component cause modelA M
 
5.2.1 dags
5.2.1 dags5.2.1 dags
5.2.1 dagsA M
 
4.5. logistic regression
4.5. logistic regression4.5. logistic regression
4.5. logistic regressionA M
 
4.3.2. controlling confounding stratification
4.3.2. controlling confounding stratification4.3.2. controlling confounding stratification
4.3.2. controlling confounding stratificationA M
 

Mehr von A M (20)

Transparency7
Transparency7Transparency7
Transparency7
 
Transparency6
Transparency6Transparency6
Transparency6
 
Transparency5
Transparency5Transparency5
Transparency5
 
Transparency4
Transparency4Transparency4
Transparency4
 
Transparency3
Transparency3Transparency3
Transparency3
 
Transparency2
Transparency2Transparency2
Transparency2
 
Transparency1
Transparency1Transparency1
Transparency1
 
5.3.5 causal inference in research
5.3.5 causal inference in research5.3.5 causal inference in research
5.3.5 causal inference in research
 
5.3.4 reporting em
5.3.4 reporting em5.3.4 reporting em
5.3.4 reporting em
 
5.3.3 potential outcomes em
5.3.3 potential outcomes em5.3.3 potential outcomes em
5.3.3 potential outcomes em
 
5.3.2 sufficient cause em
5.3.2 sufficient cause em5.3.2 sufficient cause em
5.3.2 sufficient cause em
 
5.3.1 causal em
5.3.1 causal em5.3.1 causal em
5.3.1 causal em
 
5.2.3 dags for selection bias
5.2.3 dags for selection bias5.2.3 dags for selection bias
5.2.3 dags for selection bias
 
5.2.2 dags for confounding
5.2.2 dags for confounding5.2.2 dags for confounding
5.2.2 dags for confounding
 
5.1.3 hills criteria
5.1.3 hills criteria5.1.3 hills criteria
5.1.3 hills criteria
 
5.1.2 counterfactual framework
5.1.2 counterfactual framework5.1.2 counterfactual framework
5.1.2 counterfactual framework
 
5.1.1 sufficient component cause model
5.1.1 sufficient component cause model5.1.1 sufficient component cause model
5.1.1 sufficient component cause model
 
5.2.1 dags
5.2.1 dags5.2.1 dags
5.2.1 dags
 
4.5. logistic regression
4.5. logistic regression4.5. logistic regression
4.5. logistic regression
 
4.3.2. controlling confounding stratification
4.3.2. controlling confounding stratification4.3.2. controlling confounding stratification
4.3.2. controlling confounding stratification
 

Kürzlich hochgeladen

How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17Celine George
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...Poonam Aher Patil
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Jisc
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSCeline George
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfNirmal Dwivedi
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17Celine George
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxDr. Sarita Anand
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and ModificationsMJDuyan
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.MaryamAhmad92
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - Englishneillewis46
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024Elizabeth Walsh
 

Kürzlich hochgeladen (20)

How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 

2. ph250b.14 measures of association 1

  • 2. Measures of association learning objectives 1. Define and understand the difference between the concepts of “effects” and “associations” 2. Use a contingency (2x2) table to organize information on disease occurrence in time 3. Understand the differences between the additive and multiplicative scales a. Identify the scale of each measure of association 4. Know how to calculate and interpret measures of association listed below (this includes knowing the formulas) a. Relative measures i. Cumulative incidence ratio ii. Incidence density ratio iii. Prevalence ratio iv. Odds ratio b. Absolute measures i. Attributable risk (aka risk difference) ii. Attributable risk percent iii. Population attributable risk iv. Population attributable risk percent c. Number needed to treat 5. Understand what the strength of an association captures 6. Understand what relative and absolute measures capture 7. Understand what attributable percentage measures capture
  • 3. Measures of association outline – Big picture – Scales of measures – The 2x2 table – Measures of association • Relative measures • Absolute measures • Other measures – Summary
  • 4. Big picture • In epidemiology, we often compare measures of disease frequency between different groups – Building on measures of disease module • Typically comparing disease frequency between groups with different exposures • The goal is to ascertain associations between exposures and outcomes and, ultimately, effects of exposures on outcomes
  • 5. Big picture • Reminder on the distinction between associations and effects • An association tells us about probabilities of past events – Carrying matches is associated with lung cancer
  • 6. Big picture • An effect is causal and it tells us how probabilities change if conditions change – If you remove matches from pockets in the population, does the rate of lung cancer decrease? ?
  • 7. Big picture • Measures of association quantify the strength and direction of associations between exposures and outcomes • Strength of association: – Is exposure weakly related to outcome? Strongly?
  • 8. Big picture • Direction of association: – Does exposure increase risk of disease (risk factor)? – Does exposure decrease risk (protective factor)? – Is there no association (null result)?
  • 9. Big picture • Recall counterfactual framework illustrated by an “ideal experiment” • A hypothetical study which, if we could actually conduct it, would allow us to infer causality – Population experiences one exposure and observed for outcome over a given time period – Roll back the clock – Change the exposure but leave everything else the same, observe for outcome over the same time period – Compare the outcomes under both exposures: this is the causal effect
  • 10. Big picture • In reality, the “ideal experiment” cannot be conducted • We evaluate the associations between exposures and outcomes by comparing outcomes between groups that experienced different exposures
  • 11. Big picture • Measure of association does not necessarily (or even typically) quantify a causal effect • Associations may be explained by various sources: – Causal relation – Chance (random error) – Bias (systematic error)
  • 12. Big picture • Throughout course will enumerate the methods for: – Designing studies to minimize error (systematic and random) – Assessing the roles of systematic and random error once a study is conducted (qualitatively and quantitatively) – Incorporating knowledge or assumptions about the causal process – Analytically removing or adjusting for error to the extent possible
  • 13. Big picture • These are key steps to moving towards inferring causality from associations
  • 14. Measures of association outline – Big picture – Scales of measures – The 2x2 table – Measures of association • Relative measures • Absolute measures • Other measures – Causal perspective on scales and measures – Summary
  • 15. Scales of measures • There are different scales for measuring associations between variables • Analogy: if you wanted to measure weight changes you might measure: – Weight loss/gain in lbs – Weight loss/gain as a percentage of starting weight – Change in BMI percentile • Comparison of gain/loss between people would depend on measure used
  • 16. Scales of measures • Similarly, there are different scales for quantifying the size or strength of association between an exposure and an outcome
  • 17. Scales of measures • Measures of association can be calculated on two different scales: – Relative scale (ratios) – Absolute scale (differences) • Each scale has several defining characteristics: – Range of values that the measure of association can take – Null value: value at which there is no association (value consistent with the null hypothesis of no association)
  • 18. Scales of measures • The scale of a measure of association is critical because measures on different scales capture different things • First focus on learning how the scales are different • We will discuss motivations for choosing relative versus absolute measures towards the end of this module
  • 19. Scales of measures Relative scale – ratio measures of association • The ratio of two measures of diseases is on the relative scale: – Example: (rate among the exposed)/(rate among the unexposed) – IDexposed / IDunexposed • Examples of relative measures include: Cumulative incidence ratio (CIR), incidence density ratio (IDR) • The CIR and IDR are often referred to as risk ratio or rate ratio respectively, and are abbreviated RR
  • 20. Scales of measures Relative scale – ratio measures of association • Range: zero to positive infinity • Null value: 1 • CIR = 1 or IDR = 1 means the exposure is not associated with the outcome
  • 21. Scales of measures Absolute scale – difference measures of association • The difference between two measures of disease is on the absolute scale: – Example: rate among the exposed – rate among the unexposed – IDexposed – IDunexposed • Examples of absolute measures include: attributable risk/rate (AR), population attributable risk/rate (PAR) • Note that “attributable risk” often used generically to include risks and rates
  • 22. Scales of measures Absolute scale – difference measures of association • Range: negative infinity to positive infinity • Null value: 0 • AR = 0 means the exposure is not associated with the outcome
  • 23. Measures of association outline – Big picture – Scales of measures – The 2x2 table – Measures of association • Relative measures • Absolute measures • Other measures – Causal perspective on scales and measures – Summary
  • 24. 2x2 table • Count data is typically organized with a 2x2 or contingency table • Example: with incidence data a/(a+b) = CIe • What is CI in the total population?
  • 25. 2x2 table • Incidence density data is also organized with a 2x2 or contingency table • Example: a/PTe = IDe
  • 26. 2x2 table • Note that Stata and the Kleinbaum text book present the table “backwards” with exposure on top and disease on the left • Pay attention to the orientation of the table before making calculations
  • 27. 2x2 table Note on notation – PTexposed = PTe – PTunexposed = PTu – PTtotal = PTt – Will also see applied to measures of disease including CI, ID
  • 28. Measures of association outline – Big picture – Scales of measures – The 2x2 table – Measures of association • Relative measures • Absolute measures • Other measures – Causal perspective on scales and measures – Summary
  • 29. Relative measures • Measures to be discussed – Risk/rate ratio – Prevalence ratio – Odds ratio
  • 30. Relative measures • Risk/rate ratio (RR) – aka relative risk – “Risk” in relative risk used generically to include risk or rate • Provides information about relative association between an exposure and a disease • The risk/rate of disease in the exposed is compared to the same measure among the unexposed as a ratio • RR = Rexposed / Runexposed = Re / Ru • Where R indicates either risk or rate – (i.e., CI (cumulative incidence) or ID (incidence density))
  • 31. Relative measures • RR can be used to refer generically to these relative measures • CIR is the specific term when cumulative incidence is used • IDR is the specific term when incidence density is used • Used to see term RR used generically for any relative measure (including OR, PR) but current trend is toward specific terms
  • 32. Relative measures • Interpretations of RR: • Relative difference in the risk/rate of disease between the exposed and unexposed • Interpretation of RR=5: Risk/rate of disease in the exposed is 5 times the risk/rate in the unexposed • Interpretation of RR=0.5: Risk/rate of disease in the exposed is 0.5 times the risk/rate in the unexposed
  • 33. Relative measures • Example: study of oral contraceptive (OC) use and bacteriuria among women 16-49 yrs over 1 year • RR = ? • What measures of disease incidence can we estimate from this data? • How do we compare them to estimate RR?
  • 34. Relative measures • Can estimate CIs • Take ratio to estimate RR • RR = CIR = CIe /CIu = • RR = (27/482)/(77/1908) = 1.39 • Women who use OCs have 1.39 times the risk of bacteriuria (over 1 year) compared with women who do not use OCs • Note that as with CI, CIR is only interpretable with information on the time period over which it was calculated
  • 35. Relative measures • Prevalence ratio (PR) • Provides information about relative association between an exposure and a disease, using prevalence as the measure of disease – Analogous to RR • PR = Prevexposed / Prevunexposed = Preve / Prevu
  • 36. Relative measures • Interpretations of PR: • Relative difference in the prevalence of disease between the exposed and unexposed • Interpretation of PR=5: Prevalence of disease among the exposed is 5 times the prevalence in the unexposed • Interpretation of PR=0.5: Prevalence of disease in the exposed is 0.5 times the prevalence of disease in the unexposed
  • 37. Relative measures • A brief aside on odds • Odds – two equivalent definitions – Odds = number of people with event / number of people without an event – Odds = probability of event occurring / probability of event not occurring = P / (1-P) • Example: – 10 people in a classroom of 50 have a cold – Probability of having a cold = 10/50 = 0.2 – Probability of not having a cold = 40/50 = 0.8 – Odds of having a cold = 10/40 = 0.2/0.8 = 0.25 • Odds range from 0 to positive infinity
  • 38. Relative measures • Utility of odds will become apparent when we discuss study design and analysis of epidemiologic data – When a disease is rare, odds can be modeled in place of risks with similar results – In some study designs (case-control varieties) odds estimate pseudo-risks/rates (more in study design)
  • 39.
  • 40. Relative measures • Odds ratio (OR) • Provides information about relative association between an exposure and a disease, using odds as the measure of disease – Analogous to RR • OR = (Pe /(1-Pe ))/(Pu /(1-Pu )) • OR = Odds(disease)e / Odds(disease)u JC: discuss (Disease Odds) vs. (Exposure Odds)
  • 41. Relative measures • Interpretations of OR: • Relative difference in the odds of disease between the exposed and unexposed • Interpretation of OR=5: Odds of disease is in the exposed is 5 times the odds in the unexposed • Interpretation of OR=0.5: The odds of disease in the exposed is 0.5 times the odds of disease in the unexposed • Note: it is incorrect to interpret the odds ratio as the risk/rate ratio – Exception for particular case-control study designs (more in study design module)
  • 42. Relative measures • OR always more extreme than RR (further from null) – When the disease is rare the values will be close – Note that this is not relevant for designs in which OR captures a risk/rate ratio directly (more in study design)
  • 43. Relative measures • OR versus RR • Example: – Recall the example of students having a cold • P=0.2 • Odds=0.25 – Say we wanted to compare this classroom to an office – In the office, 10 out of 100 people have a cold. • P = 10/100 = 0.1 • Odds = 10/90 = 0.111 – Exposed are students, unexposed are office workers, outcome is cold – RR comparing students to workers: RR = 0.2 / 0.1 = 2 – OR comparing students to workers: OR = 0.25 / 0.111 = 2.25
  • 44. Relative measures • OR = ? • OR = Odds(dis)exposed /Odds(dis)unexposed • OR = (a/b)/(c/d) = ad/bc • OR = (27x1831)/(77x455) = 1.41 • Women who use OCs have 1.41 times the odds of bacteriuria compared to women who do not use OCs JC: mention disease odds vs. exposure odds
  • 45. Relative measures • Formula review – RR = Re / Ru – PR = Preve / Prevu – OR = (Pe /(1-Pe ))/(Pu /(1-Pu )) – OR = Odds(dis)e /Odds(dis)u
  • 46. Relative measures • Exercise for home (discuss in lab) • Hypothetical RCT for injection drug users – Primary outcomes are cessation of drug use – HIV as a secondary outcome of interest
  • 47. Relative measures • Exercise at home / in lab • 60 people randomized to a 12-month residential detoxification program – 49 tested HIV negative at the start of the trial – At the end of the trial, 5 participants tested positive for HIV who had been negative at the start of the trial • 60 people randomized to 12-months of outpatient treatment – 50 tested HIV negative at the start of the trial – At the end of the trial, 3 participants tested positive for HIV who had been negative at the start of the trial
  • 48. Relative measures • Exercise at home / in lab • Calculate and interpret relative measures of association of potential interest from these trial results
  • 49. Measures of association outline – Big picture – Scales of measures – The 2x2 table – Measures of association • Relative measures • Absolute measures • Other measures – Summary
  • 50. Absolute measures • Measures to be discussed – Attributable risk (AR) – aka risk/rate difference (RD) – Attributable risk percent (AR%) – Population attributable risk (PAR) – Population attributable risk percent (PAR%)
  • 51. Absolute measures • Attributable risk (AR) – aka risk/rate difference (RD) • “Risk” in attributable risk used generically to include risk or rate • Provides information about absolute association between an exposure and a disease, or the excess risk or rate of disease in the exposed • AR = Rexposed – Runexposed • Where R indicates either risk or rate – (i.e., CI (cumulative incidence) or ID (incidence density))
  • 52. Absolute measures • Interpretations of AR: • Difference in risk/rate of disease between the exposed and unexposed • Excess risk/rate of disease in the exposed compared with the unexposed • AR has same units as the incidence measure used (risk (dimensionless) if CI; rate (1/time) if ID)
  • 54. Absolute measures • Example: study of oral contraceptive (OC) use and bacteriuria among women 16-49 yrs over 1 year • AR = ? • How do we compare cumulative incidence to estimate AR?
  • 55. Absolute measures • Take difference to estimate AR • AR = CIe – CIu = • AR = (27/482)–(77/1908) = 0.01566 • Women who use OCs have 0.01566 higher risk of bacteriuria compared with women who do not use OCs over 1 year • Can multiply by a population size to facilitate interpretation: 0.01566x100,000 = 1566/100,000 • Among every 100,000 women who use OCs there are 1566 excess cases of bacteriuria compared with women who do not use OCs over 1 year
  • 56. Absolute measures • Attributable risk percent (AR%) • Provides information about the excess incidence in the exposed (AR) as a percentage of incidence in the exposed population • AR% = (Rexposed – Runexposed ) / Rexposed x 100 • AR% = AR/ Rexposed x 100
  • 57. Absolute measures • Interpretations of AR%: • Percentage of all disease incidence among the exposed that is associated with the exposure • Percentage of disease incidence in the exposed that is in excess of the incidence in the unexposed
  • 58. Absolute measures Szklo Figure 3-1 100% of incidence in the exposed population AR% - percentage of disease incidence in the exposed that is in excess of the incidence in the unexposed
  • 59. Absolute measures • AR% = ? • AR% = (CIe – CIu )/CIe x 100 • AR% = (27/482)–(77/1908)/(27/482) x 100 = 28% • Of the bacteriuria incidence among women who use OCs, 28% is in excess of the incidence in women who do not use OCs
  • 60. Absolute measures • Attributable risk percent (AR%) is analogous to efficacy for an intervention (e.g., vaccine, other treatment) • The control group is considered “exposed” • The treatment group is considered “unexposed” • AR% = (Rexposed – Runexposed ) / Rexposed x 100 • Efficacy% = (Rcontrol – Rtreatment ) / Rcontrol x 100 • Percentage of disease incidence in the control group that is in excess of the incidence in the treatment group
  • 61. Absolute measures • Population attributable risk (PAR) • Provides information about the excess risk or rate of disease in the entire population (not just among the exposed as with AR) – Sometimes the AR is called the “attributable risk among the exposed” to make this distinction clear • PAR = Rtotal – Runexposed • Alternative formulation: • PAR = (AR)(Pe ) – Pe = prevalence of the exposure in the total population – See extra slides for derivation • Alternative formulation useful if estimating PAR for a total population other than your study population for which you have an estimate of Pe
  • 62. Absolute measures • Interpretations of PAR: • Excess risk/rate of disease in the total population compared with the unexposed • If association is believed to be causal, PAR can be used to estimate the impact of an exposure on the health of a population of interest • PAR will never be larger than AR in a given population • PAR has same units as the incidence measure used (risk (dimensionless) if CI; rate (1/time) if ID)
  • 63. Absolute measures • PAR = ? • PAR = CIt – CIu = • PAR = (104/2390)–(77/1908) = 0.00316 • In the total population of women there is 0.00316 higher risk of bacteriuria compared with women who do not use OCs • Can multiply by a population size to facilitate interpretation: 0.00316x100,000 = 316/100,000 • There are 316 excess cases of bacteriuria for every 100,000 women in the total population compared with women who do not use OCs JC: review NNT
  • 64. Absolute measures • Comparison of AR and PAR • AR = 1566/100,000 • PAR = 316/100,000 • PAR < AR • Why is this the case?
  • 65. Absolute measures • Population attributable risk percent (PAR%) • Provides information about the excess incidence in the total population (PAR) as a percentage of incidence in the total population • PAR% = (Rtotal – Runexposed ) / Rtotal x 100 • PAR% = (PAR / Rtotal ) x 100
  • 66. Absolute measures • PAR% = ? • PAR% = (CIt – CIu )/CIt x 100 • PAR% = (104/2390)–(77/1908)/(104/2390) x 100 = 7.3% • Of the bacteriuria incidence in the total population of women, 7% is in excess of the incidence in women who do not use OCs
  • 67. Absolute measures • Comparison of AR% and PAR% • AR% = 28% • PAR% = 7% • PAR% < AR% • Why is this the case?
  • 68. Absolute measures Szklo Figure 3-2 Exposure uncommon in total population Exposure common in total population
  • 69. Absolute measures • AR versus PAR – The AR depends only on the strength of the relation between the exposure and the disease – The PAR depends both on the strength of the relation and the prevalence of the exposure
  • 70. Absolute measures • AR = Rexposed – Runexposed • PAR = Rtotal – Runexposed • Think of Rtotal (risk/rate in total population) as a weighted average of the risk/rate among the exposed and unexposed • Weighted by the prevalence of the exposure (Pe ): – Rt = (Pe )Re + (Pu )Ru – Rt = (Pe )Re + (1-Pe )Ru – When Pe is close to 1 (and 1- Pe is close to 0), Rt is close to Re and thus PAR is close to AR – When Pe is close to 0 (and 1- Pe is close to 1), Rt is close to Ru (not Re ) and thus PAR is much smaller than AR
  • 71. Absolute measures Szklo Figure 3-2 Prevalence of exposure not depicted here, but reflected in different magnitudes of PAR Pe is close to 0, Rt is close to Ru (not Re ) and thus PAR is much smaller than AR Pe is close to 1, Rt is close to Re and thus PAR is close to AR
  • 72. – An exposure with a large AR can have a low PAR if the exposure is uncommon – Example: extremely carcinogenic but rare chemical • Removing an exposure with a large AR but a small PAR would not improve the overall health of the population appreciably Absolute measures
  • 73. Absolute measures • There are some study designs (case-control) for which measures of disease cannot be estimated – only the odds ratio (OR), a relative measure, can be calculated (more in study design) • For these studies, there are alternative formulas for the absolute measures that can be applied – they require making some assumptions and/or bringing in outside information
  • 74. Absolute measures • Alternative formulation for AR% • Additional information/assumptions – OR estimates risk/rate ratio • AR% = [(OR – 1) / OR] x 100 • Alternative formula is a simple algebraic transformation of original formula – Dividing (Re – Ru ) / Re by Ru – ((Re /Ru )-(Ru /Ru )) / (Re /Ru ) – (RR-1)/RR – RR estimated by OR* – *How well OR estimates risk or rate ratio depends on design of case-control study and on how common disease is for cumulative case-control
  • 75. Absolute measures • Alternative formulation for PAR% • Additional information/assumptions – OR estimates risk/rate ratio – Prevalence of exposure in the total population can be estimated as the proportion of non-diseased individuals exposed, or from another source: Pe – PAR% = [((Pe )(OR-1)) / ((Pe )(OR-1) + 1)] x 100 • Note Miettinen 1974 other formulation – PAR% = AR% x (proportion exposed among diseased) – Will provide a different estimate than formulation above
  • 76. Absolute measures • Derivation of alternative formula for PAR% • Think of Rtotal (risk/rate in total population) as a weighted average of the risk/rate among the exposed and unexposed • Weighted by the prevalence of the exposure: – Rt = (Re )(Pe ) + (Ru )(1-Pe ) • Substitute into original equation – PAR% = (Rt – Ru )/ Rt – PAR% = ((Re )(Pe ) + (Ru )(1-Pe ) – Ru )/ (Re )(Pe ) + (Ru )(1-Pe ) – PAR% = ((Re )(Pe ) + (Ru )-(Ru Pe ) – Ru )/ (Re )(Pe ) + (Ru )-(Ru Pe )
  • 77. Absolute measures • Divide numerator and denominator by Ru – PAR% = ((Re )(Pe )/Ru + 1 - Pe –1)/ (Re )(Pe )/Ru + 1-Pe – PAR% = ((Re )(Pe )/Ru - Pe )/ (Re )(Pe )/Ru - Pe + 1 – PAR% = (Pe (Re /Ru - 1)/ Pe (Re /Ru – 1) + 1 • Note that RR = Re / Ru therefore if OR estimates RR – PAR% = [(Pe )(OR-1)] / [(Pe )(OR-1) + 1]
  • 78. Absolute measures • Alternative formulation for AR, PAR • Additional information/assumptions – OR estimates risk/rate ratio – Prevalence of exposure in the total population can be estimated as the proportion of non-diseased individuals exposed, or from an outside source: Pe – Risk/rate for the total population can be estimated, usually from an outside source: Rt • Ru = (Rt ) / ((OR)(Pe ) + (1- Pe )) • Re = (OR)(Ru ) • AR = Re -Ru • PAR = Rt -Ru
  • 79. Absolute measures • Derivation of alternative formulas for AR and PAR • Think of Rtotal (risk/rate in total population) as a weighted average of the risk/rate among the exposed and unexposed • Weighted by the prevalence of the exposure: – Rt = (Re )(Pe ) + (Ru )(1- Pe ) • Note that RR = Re / Ru therefore if OR estimates RR – Re = (OR)(Ru ) – Rt = (OR)(Ru )(Pe ) + (Ru )(1- Pe ) • Solve for Ru – Ru = (Rt ) / ((OR)(Pe ) + (1- Pe )) – Re = (OR)(Ru )
  • 80. Absolute measures • Formula review – AR = Rexposed – Runexposed – AR% = [(Rexposed – Runexposed ) / Rexposed ] x 100 – PAR = Rtotal – Runexposed – PAR = (AR)(Pe ) – PAR% = [(Rtotal – Runexposed ) / Rtotal ] x 100 – AR% = [(OR – 1) / OR] x 100 – PAR% = [((Pe )(OR-1)) / ((Pe )(OR-1) + 1)] x 100 – AR = (OR)(Ru ) - (Rt / [(OR)(Pe ) + (1- Pe )]) – PAR = Rt - [(Rt )/ ((OR)(Pe ) + (1- Pe ))]
  • 81. Properties of scales • Absolute measures are symmetrical around 0 – Exposure associated with higher risk/rate is indicated by a positive value (e.g., AR = 0.01) – Exposure associated with lower risk/rate is indicated by a negative value (e.g., AR = -0.01) – Magnitudes of negative and positive ARs with same numeric value are equivalent but in opposite directions (e.g., AR = 0.01 same magnitude as AR = -0.01)
  • 82. Properties of scales • Relative measures are asymmetrical around 1 – Exposure associated with higher risk/rate is indicated by a value >1 (e.g., RR = 2) – Exposure associated with lower risk/rate is indicated by a value 0-1 (e.g., RR = 0.5) – To calculate a relative measure’s equivalent on the other side of the null you have to take its inverse (1/RR) • RR = 2 is of equivalent strength to a protective factor with RR = 1/2 = 0. 5
  • 83. Properties of scales • Relative measures – on arithmetic and log scales
  • 84. Properties of scales • Due to the asymmetry of relative measures – Log-transformed (natural log) axes are often used to graphically present relative measures – Variances of relative measures are calculated on the log scale, and any calculations based on the variance (e.g., confidence intervals) are completed on the log scale before returning to the relative measure scale
  • 85. Variance estimates • Approximate variance estimates for measures of association (some are in Szklo appendix A) • Variance of: – ln(IDR) = (1/a) + (1/b) – ln(CIR) = (b / a(a+b)) + (d / c(c+d)) – ln(OR) = (1/a) + (1/b) + (1/c) + (1/d) • Small cells inflate variance
  • 86. Other measures • Number needed to treat (NNT) – Related to attributable risk • Provides information about the number of people you would have to remove exposure from to prevent one case of disease • NNT = 1 / AR – The number (of exposed persons) needed to treat is the reciprocal of the attributable risk • Not appropriate unless you believe the relation is causal
  • 87. Other measures • Example of OCs and bacteriuria • AR = 0.01566 • NNT = 1/AR = 1/0.01566 = 64 • 64 OC users need to stop using OCs to eliminate one case of bacteriuria
  • 88. Absolute measures • Exercise • Recall our hypothetical RCT • 60 people randomized to a 12-month residential detoxification program – 49 tested HIV negative at the start of the trial – At the end of the trial, 5 participants tested positive for HIV who had been negative at the start of the trial • 60 people randomized to 12-months of outpatient treatment – 50 tested HIV negative at the start of the trial – At the end of the trial, 3 participants tested positive for HIV who had been negative at the start of the trial
  • 89. Measures of association outline – Big picture – Scales of measures – The 2x2 table – Measures of association • Relative measures • Absolute measures • Other measures – Summary
  • 90. Measures of association outline – Big picture – Scales of measures – The 2x2 table – Measures of association • Relative measures • Absolute measures • Other measures – Summary
  • 91. Summary • Measures of disease among groups with different exposures are compared in observational epidemiology • These comparisons are made with measures of association between exposures and diseases • Introduced to a variety of measures of association broadly classified as relative or additive Re /Ru Re -Ru
  • 92. Summary • While the relative have been more commonly used, the additive have been argued to be better for purposes of identifying etiology and estimating public health impact • Insights from two of the theoretical causal models elucidate why this argument has been made, and elucidate what relative and absolute measures estimate
  • 93. Summary Variety of terms used for measures of association discussed today • “Risk” often used generically to include rates (ID), risks (CI) and even prevalence
  • 94. Summary Relative measures • Cumulative incidence ratio (CIR) • Incidence density ratio (IDR) • Prevalence ratio (PR) • Rate/risk ratio = Relative risk (RR) • Odds ratio (OR)
  • 95. Summary Absolute measures • Attributable risk (AR) = Risk/rate difference = Excess risk • Population attributable risk (PAR) = Population risk/rate difference • Attributable risk percent (AR%) = Etiologic fraction = Attributable proportion among the exposed • Population attributable risk percent (PAR%) = Attributable proportion in the total population
  • 96. Summary • Have only examined what are called “crude” measures of association – Compared exposed and unexposed populations without considering other variables that may differ between the populations – Later in the course we will discuss how to deal analytically with other variables that may be different between the exposed and unexposed and that thus make the populations not exchangeable (to be discussed in confounding)
  • 97.
  • 99. Absolute measures • Alternative formulation: • PAR = (AR)(Pe ) • Where does this come from? • PAR = Rt – Ru • PAR = [(Pe )Re + (1-Pe )Ru ] - Ru • PAR = (Pe )Re + Ru - (Pe )Ru - Ru • PAR = (Pe )Re - (Pe )Ru • PAR = (Re - Ru )(Pe ) • PAR = (AR)(Pe )
  • 100. Causal perspective • When we estimate AR, PAR, AR% or PAR% (whether with counterfactual populations or in observational data) they will only provide a lower bound of the true incidence or fraction of incidence due to the exposure mechanistically (think of the pies) – unless exposure acts independent of background causes
  • 101. Causal perspective Szklo Figure 3-1 Incidence caused by mechanism including exposure In absence of exposure, another causal mechanism (background cause) was completed within study time frame
  • 102. Causal perspective Population unexposed for a given time period, population exposed over same period Rates/risks compared are causal p1+p3 p1+p2 Counterfactual Counterfactual
  • 103. Causal perspective • Extreme example – mechanism including your exposure causes disease 1 day earlier than would have occurred otherwise from background causes • In the exposed, your exposure mechanistically caused 100% of disease • In your data the rate of disease appears the same in the exposed and unexposed and you infer 0% of disease caused by your exposure (ME3 p63, 297 for elaborated discussion) • Type 2 (slide 74) individuals (in this example 100% of them) had disease caused by exposure when exposed, but caused by another mechanism when not exposed • Thus incidence due to specific causal mechanisms cannot be estimated from epidemiologic data
  • 104. Relative measures • OR – exposure OR vs disease OR – Exposure OR = odds(E|D)/odds(E|Dnot) – EOR = (a/c)/(b/d) = ad/bc – Disease OR = odd(D|E)/odds(D|Enot) – DOR = (a/b)/(c/d) = ad/bc – Exposure OR = disease OR